Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. | VKTX | $34.87 | $4.07B | — | |
| Telix Pharmaceuticals Limited | TLX | $11.94 | $4.06B | 119.4 | — |
| iRhythm Holdings, Inc. | IRTC | $123.07 | $4.06B | — | |
| Tarsus Pharmaceuticals, Inc. | TARS | $90.78 | $3.98B | — | |
| Iovance Biotherapeutics, Inc. | IOVA | $8.79 | $3.98B | — | |
| Adaptive Biotechnologies Corporation | ADPT | $24.28 | $3.87B | — | |
| Catalyst Pharmaceuticals Inc | CPRX | $31.49 Jul 21, 2026 | $3.85B | 18.2 | — |
| IDEAYA Biosciences, Inc. | IDYA | $39.86 | $3.85B | — | |
| Amylyx Pharmaceuticals, Inc. | AMLX | $34.10 | $3.80B | — | |
| Pulse Biosciences, Inc. | PLSE | $53.24 | $3.80B | — | |
| Tango Therapeutics, Inc. | TNGX | $22.52 | $3.80B | — | |
| Arcus Biosciences, Inc. | RCUS | $29.66 | $3.73B | — | |
| AbCellera Biologics Inc. | ABCL | $11.43 | $3.70B | — | |
| Curaleaf Holdings, Inc. | CURA.TO | CA$13.72 | CA$3.63B | — | |
| Option Care Health, Inc. | OPCH | $24.21 | $3.63B | 18.3 | — |
| Organon & Co. | OGN | $13.78 | $3.62B | 17.7 | 0.58% |
| GRAIL, Inc. | GRAL | $80.34 | $3.59B | — | |
| Denali Therapeutics Inc. Common Stock | DNLI | $22.28 | $3.56B | — | |
| National HealthCare Corporation | NHC | $218.64 | $3.42B | 24.9 | 1.21% |
| Veracyte, Inc. | VCYT | $42.53 | $3.42B | 30.4 | — |
| Structure Therapeutics Inc. | GPCR | $47.34 | $3.38B | — | |
| TransMedics Group, Inc. | TMDX | $89.98 | $3.12B | 23.3 | — |
| Celldex Therapeutics, Inc. | CLDX | $39.68 | $3.12B | — | |
| uniQure N.V. | QURE | $44.50 | $3.09B | — | |
| Beam Therapeutics Inc. | BEAM | $29.66 | $3.06B | — | |
| Disc Medicine, Inc. | IRON | $79.23 | $3.04B | — | |
| Immunome, Inc. | IMNM | $26.76 | $3.04B | — | |
| Warby Parker Inc. | WRBY | $24.35 | $3.01B | 405.8 | — |
| Arcutis Biotherapeutics, Inc. | ARQT | $23.90 | $3.00B | 108.6 | — |
| MBX Biosciences, Inc. | MBX | $61.72 | $2.97B | — | |
| NewAmsterdam Pharma Company N.V. | NAMS | $25.40 | $2.97B | — | |
| Aveanna Healthcare Holdings Inc. | AVAH | $13.58 | $2.96B | 10.8 | — |
| Extendicare Inc. | EXE.TO | CA$31.10 | CA$2.96B | 23.7 | 1.70% |
| Zai Lab Limited American Depositary Shares | ZLAB | $26.23 | $2.94B | — | |
| Brookdale Senior Living Inc. | BKD | $11.77 | $2.81B | — | |
| Alignment Healthcare, Inc. | ALHC | $13.54 | $2.81B | 71.3 | — |
| SELLAS Life Sciences Group, Inc. | SLS | $13.86 | $2.80B | — | |
| Soleno Therapeutics, Inc. | SLNO | $53.01 May 18, 2026 | $2.76B | 27.5 | — |
| AtaiBeckley Inc. | ATAI | $7.39 | $2.74B | — | |
| Nurix Therapeutics, Inc. | NRIX | $26.14 | $2.71B | — | |
| Maravai LifeSciences Holdings, Inc. | MRVI | $7.32 | $2.71B | — | |
| Privia Health Group, Inc. | PRVA | $20.66 | $2.64B | 93.9 | — |
| CareDx, Inc. | CDNA | $50.88 | $2.63B | 24.0 | — |
| AtriCure, Inc. | ATRC | $51.52 | $2.62B | 245.3 | — |
| Acadia Healthcare Company, Inc. | ACHC | $28.13 | $2.62B | — | |
| Viridian Therapeutics, Inc. | VRDN | $22.92 | $2.60B | — | |
| Axogen, Inc. | AXGN | $48.28 | $2.60B | — | |
| Vera Therapeutics, Inc. | VERA | $35.89 | $2.59B | — | |
| Guardian Pharmacy Services, Inc. | GRDN | $40.77 | $2.58B | 39.2 | — |
| Neogen Corporation | NEOG | $11.83 | $2.58B | — |
Viking Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.07B
- P/E
- unprofitable
Telix Pharmaceuticals Limited
Healthcare / Biotechnology
- Market Cap
- $4.06B
- P/E
- 119.4
iRhythm Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $4.06B
- P/E
- unprofitable
Tarsus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.98B
- P/E
- unprofitable
Iovance Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.98B
- P/E
- unprofitable
Adaptive Biotechnologies Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $3.87B
- P/E
- unprofitable
Catalyst Pharmaceuticals Inc
Healthcare / Biotechnology
- Market Cap
- $3.85B
- P/E
- 18.2
IDEAYA Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.85B
- P/E
- unprofitable
Amylyx Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.80B
- P/E
- unprofitable
Pulse Biosciences, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $3.80B
- P/E
- unprofitable
Tango Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.80B
- P/E
- unprofitable
Arcus Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.73B
- P/E
- unprofitable
AbCellera Biologics Inc.
Healthcare / Biotechnology
- Market Cap
- $3.70B
- P/E
- unprofitable
Curaleaf Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$3.63B
- P/E
- unprofitable
Option Care Health, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $3.63B
- P/E
- 18.3
Organon & Co.
Healthcare / Drug Manufacturers - General
- Market Cap
- $3.62B
- P/E
- 17.7
- Dividend Yield
- 0.58%
GRAIL, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.59B
- P/E
- unprofitable
Denali Therapeutics Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $3.56B
- P/E
- unprofitable
National HealthCare Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $3.42B
- P/E
- 24.9
- Dividend Yield
- 1.21%
Veracyte, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.42B
- P/E
- 30.4
Structure Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $3.38B
- P/E
- unprofitable
TransMedics Group, Inc.
Healthcare / Medical Devices
- Market Cap
- $3.12B
- P/E
- 23.3
Celldex Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.12B
- P/E
- unprofitable
uniQure N.V.
Healthcare / Biotechnology
- Market Cap
- $3.09B
- P/E
- unprofitable
Beam Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $3.06B
- P/E
- unprofitable
Disc Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.04B
- P/E
- unprofitable
Immunome, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.04B
- P/E
- unprofitable
Warby Parker Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $3.01B
- P/E
- 405.8
Arcutis Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $3.00B
- P/E
- 108.6
MBX Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.97B
- P/E
- unprofitable
NewAmsterdam Pharma Company N.V.
Healthcare / Biotechnology
- Market Cap
- $2.97B
- P/E
- unprofitable
Aveanna Healthcare Holdings Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.96B
- P/E
- 10.8
Extendicare Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$2.96B
- P/E
- 23.7
- Dividend Yield
- 1.70%
Zai Lab Limited American Depositary Shares
Healthcare / Biotechnology
- Market Cap
- $2.94B
- P/E
- unprofitable
Brookdale Senior Living Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.81B
- P/E
- unprofitable
Alignment Healthcare, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $2.81B
- P/E
- 71.3
SELLAS Life Sciences Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.80B
- P/E
- unprofitable
Soleno Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.76B
- P/E
- 27.5
AtaiBeckley Inc.
Healthcare / Biotechnology
- Market Cap
- $2.74B
- P/E
- unprofitable
Nurix Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.71B
- P/E
- unprofitable
Maravai LifeSciences Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.71B
- P/E
- unprofitable
Privia Health Group, Inc.
Healthcare / Health Information Services
- Market Cap
- $2.64B
- P/E
- 93.9
CareDx, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $2.63B
- P/E
- 24.0
AtriCure, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $2.62B
- P/E
- 245.3
Acadia Healthcare Company, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.62B
- P/E
- unprofitable
Viridian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.60B
- P/E
- unprofitable
Axogen, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.60B
- P/E
- unprofitable
Vera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.59B
- P/E
- unprofitable
Guardian Pharmacy Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.58B
- P/E
- 39.2
Neogen Corporation
Healthcare / Medical Devices
- Market Cap
- $2.58B
- P/E
- unprofitable
Showing 201–250 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.